Michael L. Levitz

2021 - Anika Therapeutics

In 2021, Michael L. Levitz earned a total compensation of $1.6M as EVP, Chief Financial Officer and Treasurer at Anika Therapeutics, a 14% decrease compared to previous year.

Compensation breakdown

Bonus$205,362
Option Awards$453,004
Salary$456,400
Stock Awards$452,710
Other$21,380
Total$1,588,856

Levitz received $456.4K in salary, accounting for 29% of the total pay in 2021.

Levitz also received $205.4K in bonus, $453K in option awards, $452.7K in stock awards and $21.4K in other compensation.

Rankings

In 2021, Michael L. Levitz's compensation ranked 7,008th out of 12,415 executives tracked by ExecPay. In other words, Levitz earned more than 43.6% of executives.

ClassificationRankingPercentile
All
7,008
out of 12,415
44th
Division
Manufacturing
3,071
out of 5,505
44th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
405
out of 801
49th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
256
out of 522
51st
Industry
Surgical and Medical Instruments and Apparatus
164
out of 327
50th
Source: SEC filing on April 27, 2022.

Levitz's colleagues

We found four more compensation records of executives who worked with Michael L. Levitz at Anika Therapeutics in 2021.

2021

Cheryl Blanchard

Anika Therapeutics

Chief Executive Officer

2021

David Colleran

Anika Therapeutics

General Counsel

2021

Thomas Finnerty

Anika Therapeutics

EVP, Human Resources

2021

James Loerop

Anika Therapeutics

EVP, Business Development and Strategic Planning

News

You may also like